English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Multimodal rheumatologic complex therapy (MRCT) delivers various modalities of physical therapy (PT) to patients with rheumatic diseases. We conducted a monocentric retrospective analysis of the effects of MRCT on pain and disease activity in patients with primary (PFM) and secondary fibromyalgia (SFM). 102 treatment episodes (N) applied to 83 patients (n) with PFM ( N  = 50;  n  = 39) and SFM ( N  = 52,  n  = 44) were analysed. Of the latter, 23 had rheumatoid arthritis (RA) and 21 spondyloarthritis (SpA). We evaluated changes in pain intensity, functional status and disease activity before and after a MRCT episode. In addition, we assessed influences of various patient characteristics and analysed treatment responses in PFM and SFM. MRCT resulted in significant reduction of pain (NRS,  p  &lt; 0.0001) and disease activity (FIQ,  p  = 0.001). In SFM, disease activity of the underlying disease (i.e. RA or SpA) was significantly reduced. Various aspects of the disease did not have a significant effect on the outcome parameters. Treatment effects were not significantly different in PFM and SFM. MRCT significantly decreases pain and disease activity in patients with FM, irrespective of the course of disease, and is equally effective in both PFM and SFM, thus underlining the importance of PT in the treatment of FM.

Multimodal physical therapy for treating primary and secondary fibromyalgia – German multimodal rheumatologic complex treatment